PSORIASIS

PSORIASIS

Displaying 10 out of 9 results

  1. Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an emplo

    Bristol-Myers Squibb wins antitrust approval to buy Celgene, but must divest psoriasis drug

    Bristol-Myers Squibb Co and Celgene Corp have won U.S. antitrust approval for their merger on condition that they sell Celgene's psoriasis drug ...
  2. File photo of an Amgen sign at the company's office in South San Francisco

    Amgen to buy Celgene psoriasis drug Otezla for US$13.4 billion

    Amgen Inc said on Monday it would buy Celgene Corp's psoriasis drug Otezla for US$13.4 billion in cash, clearing the way for Bristol-Myers ...
  3. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Bristol-Myers plans to divest Celgene's psoriasis drug

    Bristol-Myers Squibb Co said on Monday it would divest Celgene Corp's psoriasis treatment Otezla as the companies look to gain approval for their ...
  4. New Content Item

    Bausch Health's lotion for plaque psoriasis wins FDA approval

  5. FILE PHOTO:  A trader works by the post that trades AbbVie on the floor of the New York Stock Excha

    AbbVie's Skyrizi drug to treat psoriasis wins US approval

    AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when ...
  6. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California

    Pharmaceuticals drive J&J to better-than-expected quarterly profit

    Johnson & Johnson reported first-quarter revenue above analysts' estimates on Tuesday, driven partly by demand for its Stelara treatment for ...
  7. New Content Item

    Celgene profit beats as psoriasis drug sales surge

  8. FILE PHOTO - A Johnson & Johnson building is shown in Irvine, California

    J&J says its psoriasis drug superior to Novartis treatment in study

    Johnson & Johnson said its drug Tremfya was found to be more effective than a rival medicine from Novartis AG in reducing the severity and ...
  9. (ry) psoriasis 4

    Tackling that itch: Demand for help with skin issues on the rise in Singapore

    More awareness is part of the reason behind the increase, according to dermatologists.